We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Philips to Acquire Leading Brazilian Critical Care Company

By HospiMedica staff writers
Posted on 13 May 2008
In a move that further bolsters its strategy of penetrating high-growth emerging critical care markets by way of economically priced devices, Netherlands-based Royal Philips Electronics announced its agreement to acquire Dixtal Biomédica e Tecnologia, a leading Brazilian manufacturer of patient monitoring and critical care devices.

Dixtal (São Paulo, Brazil) is a leading Brazilian manufacturer of in-hospital patient monitoring, anesthesia, ventilation, and ECG (Electrocardiogram) equipment as well as other sensors for vital sign measurements. More...
Dixtal will become part of the Patient Monitoring business within Philips' Healthcare sector. Philips expects Dixtal's financial results to be consolidated as of the third quarter of 2008. The terms of the deal were not disclosed.

The announcement marks another step Philips (Amsterdam, The Netherlands) is taking to expand its presence in high-growth healthcare markets in emerging economies, following the company's earlier announced acquisitions of healthcare companies Shenzhen Goldway in China and VMI Sistemas Medicos in Brazil.

In commenting on the deal, Mr. Daurio Speranzini Júnior, Senior Vice-President of Philips Healthcare Latin America, said: "Emerging markets represent a real opportunity for us to keep growing our healthcare business at Philips. If you just take Latin America, our segment of the healthcare market in 2007 was estimated to be valued at approximately EUR 1.2 billion, and growing at twice the rate of developed markets. Acquiring Dixtal will help us further tap into that growth.”

Mr. Speranzini Júnior continued, "In the hospital, a key component of critical care is patient monitoring, and Philips already enjoys a leading global position in this market. Acquiring Dixtal will not only extend Philips' product portfolio to include Dixtal's mid- to economy-range patient monitoring products, but through this move we'll gain access to other key components of critical care – Dixtal's anesthesia machines and its invasive ventilation products. Accordingly, this acquisition complements Philips' recent move into the non-invasive ventilation business through our acquisition earlier this year of US-based Respironics. And since Dixtal and Philips use the same distribution channels vis-à-vis hospitals for all of our critical care businesses, we can expect significant synergies coming out of this collaboration.”

Founded in 1978, Dixtal is a privately held healthcare company headquartered in São Paulo, Brazil. Dixtal employs approximately 300 people, mainly in Brazil, of which 60 work in R&D. "Since being founded 30 years ago, we've focused on helping hospitals provide the optimum in critical care. We believe that combining our culture and capabilities with those of a world class company like Philips will help us serve society better and expand our presence in Latin America and beyond,” said Albert Holzhacker, President of Dixtal.

Over the last four years, Dixtal has tripled its revenues. Following completion of the acquisition, growth is expected to accelerate further as Philips leverages Dixtal's contacts with local hospitals and distributors, while Dixtal capitalizes on Philips' global presence for its products.

Philips has an extensive presence in critical care through its leading position in the global patient monitoring market, which in 2007 was estimated at approximately EUR 2 billion.


Related Links:
Dixtal
Philips

Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
Electrode Solution and Skin Prep
Signaspray
External Defibrillator
HeartSave Y | YA
Imaging Table
Stille imagiQ2
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.